检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:何明生[1] 陈燕[1] 吴裕丹[1] 喻东姣[1] 莫志成 周晶 宋今丹
出 处:《癌症》1999年第3期246-249,共4页Chinese Journal of Cancer
基 金:卫生部科学研究基金
摘 要:目的:建立检测细胞内柔红霉素(DNR)的荧光直方图诊断白血病细胞耐药的方法。材料与方法:选取15例临床耐药的急性髓性白血病(AML),5例初治AML进行研究,用流式细胞仪(FCM)检测细胞内DNR的荧光强度,根据其强弱程度划分成耐药区和药敏区,其直方图主峰左移(LSMP)诊断为耐药;直方图右移(RSMP)诊断为药敏。耐药指数(DRI),即R/S(R为耐药细胞数,S为药敏细胞数)≥2为耐药,<2为药敏。荧光指数(FI)=平均荧光强度×DRI,FI≥200为耐药,FI<200为药敏。结果:初治5例AML中,4例为RSMP,DRI=023~113,FI=50~160,诊断为药敏;另一例为LSMP,RI=360,FI=367,诊断为原发耐药。15例临床耐药的AML中,12例为LSMP,DRI=259~1772,FI=265~1041,诊断为经典耐药;其余3例为RSMP,DRI=039~067,FI=57~83,诊断为再生耐药。结论:用FCM检测白血病细胞内DNR的荧光直方图,结合DRI、FI以及临床耐药表现和耐药细胞荧光强度的诊断界点的方法,我们可以快速、简便、直观地在临床上及时发现和评价AML耐药的?Objective: To develop a fluorescent histogram of intracellular daunorubicin(DNR) as a diagnostic method for drug resistance in acute myeloid leukemia(AML). Methods: 15 patients with clinically diagnosed drugresistant AML and 5 patients with previously untreated AML were studied. The intensity of fluorescence of intracellular DNR and the fluorescent histogram were determined by flow cytometer(FCM).According to a degree of the intensity, both drugresistant andsensitive zones were marked off. Left shift of main peak(LSMP) with the fluoresent histogram may be diagnosed as drug resistance, and right shift of main peak(RSMP) as drug sensitivity. R/S stood for drug resistant index(DRI);R for the number of drugresistant cells, and S for drugsensitive cells. DRI2 was drugresistant or DRI< 2 was drugsensitive. Fluorescent index(FI) was the product of mean fluorescent intensity (MFI) multiplied by DRI. FI200 meant drugresistant, while FI< 200 meant drugsensitive. Results: Among 5 patients with previously untreated AML, 4 patients were diagnosed as drugsensitive for RSMP, DRI=023113,FI=50160,and one patient was diagnosed as primary drugresistant for LSMP,DRI=360, FI=367 In 15 patients with clinically drugresistant AML,12 patients were diagnosed as classical resistance for LSMP,DRI=2591772,and FI=2651041,and 3 patients as regrowth drug resistance for RSMP,DRI=039067,and FI=5783 Conclusion: Clinically, it was a rapid, convenient and visual way, which by FCM mapping the fluorescent histogram of intracellular DNR, in combination with DRI, FI, a clinically drugresistant manifestation and a cutoff point for diagnosis of the fluorescent intensity of drugresistant cells, we may in good time find and value a type and a degree of drug resistance to AML. Moreover ,it may provide a basis for working out an individually
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.188